|
51 |
Department of Pharmaceuticals invites applications to fill up the post of Chief Executive Officer (CEO) in Pharmaceutical and Medical Devices Bureau of India (PMBI) |
|
|
52 |
Extension of last date for receipt of applications- Inviting applications from the retired employees of Central Govt. Departments/ Public Sector Undertaking for rendering their services as Consultant |
|
|
53 |
Inviting applications from the retired employees of Central Govt. Departments/ Public Sector Undertaking for rendering their services as Consultant in Department of Pharmaceuticals, Ministry of Chemical and Fertilizers - regarding. |
|
|
54 |
Frequently Asked Questions (FAQs) regarding the Promotion of Research and Innovation in Pharma MedTech (PRIP) Scheme. |
|
|
55 |
Department of Pharmaceuticals invites Expression of Interest (EoI) from interested entities under the PRIP scheme |
|
|
56 |
Applications for the posts of Director of NIPER-Kolkata |
|
|
57 |
Apex Committee Order dated 23.12.2024 in case of M/s AbbVie Healthcare India Pvt. Ltd. under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 |
|
|
58 |
Vacancy circular for engagement of Consultants (02 Nos.) on contractual basis- reg. |
|
|
59 |
Invitation of applications under the Scheme Assistance to Pharmaceutical Industry for Common Facilities (API-CF) w.e.f. 11.12.2024 to 13.01.2025. |
|
|
60 |
Operational Guidelines for the Scheme 'Strengthening of Medical Device Industry' |
|
|
61 |
Selection for the post of Managing Director, Karnataka Antibiotics & Pharmaceuticals Limited (KAPL), a schedule 'C' CPSE- Advertisement reg. |
|
|
62 |
Press Releases :PM to inaugurate five projects under the PLI scheme for medical devices and bulk drugs |
|
|
63 |
Modification in the guidelines of Production Linked Incentive (PLI) Scheme Bulk Drugs |
|
|
64 |
Notification of the modification in the clauses under subscheme Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS) - reg. |
|
|
65 |
14 सितम्बर, 2024 को हिन्दी दिवस के उपलक्ष्य में सचिव (औषध) का संदेश |
|
|
66 |
Message from Hon'ble Minister (C&F) on Swachhta Pakhwada During 1-15 September 2024 |
|
|
67 |
Message from Hon'ble MoS (C&F) on Swachhta Pakhwada During 1-15 September 2024 |
|
|
68 |
Standing Order - Circular No. 2 of 2024 under UCPMP-2024 |
|
|
69 |
Additional charge of the post of Chairman, National Pharmaceuticals Pricing Authority (NPPA) assigned to Shri Arunish Chawla, Secretary, Department of Pharmaceuticals |
|
|
70 |
Corrigendum (date & technical) Regarding Tender for Selection of Consulting Firm for strategy development and implementation of the Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector Scheme. |
|
|
71 |
Invitation for a pre-bid meeting regarding Tender for Selection of Consulting Firm for strategy development and implementation of the Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector Scheme - Reg. |
|
|
72 |
Study report on Bridging Academia-Industry Gap to achieve Self-reliance |
|
|
73 |
Study Report on Impact of the Drug Price Control Order (DPCO) 2013 on the price of Cardiac stents Knee implants and six medical devices on industry and consumers in terms of availability and affordability |
|
|
74 |
Standing Order- Circular No. 1 of 2024 under UCPMP-2024 |
|
|
75 |
Recruitment of Young Professionals on contract basis in Department of Pharmaceuticals- reg. |
|
|
76 |
Advertisement for engagement of Young Professionals (2), Junior Consultant (1), Senior Consultant (1) for Project Management Unit of PRIP Scheme. |
|
|
77 |
Term of Reference for Hiring of Young Professionals (2), Junior Consultant (1), Senior Consultant (1) for Project Management Unit of PRIP Scheme |
|
|
78 |
Recruitment of Young Professionals on contract basis in Department of Pharmaceuticals- reg. |
|
|
79 |
Revised Guidelines for the Scheme - Strengthening of Pharmaceuticals Industry (SPI), Dated 14th March 2024. |
|
|
80 |
Study report on An analysis on leveraging the patent cliff, with drug sales worth USD 251 billion going off-patent and to analyses the different drug pricing methodologies particularly w.r.t. these patented drugs going off-patent |
|
|
81 |
Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 - reg |
|
|
82 |
Public Notice dated 12.03.2024: Inviting details of local manufacturers of Medical Devices |
|
|
83 |
Modifications in the guidelines of Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country (PLI BD)- reg |
|
|
84 |
Modifications in the guidelines of Production Linked Incentive scheme for Promoting Domestic Manufacturing of Medical Devices (PLI MD) relating to revision of Scheduled Commercial Operation Date (SCOD) and invocation of bank guarantee - reg |
|
|
85 |
Constitution of a Committee for Reforms in the Pricing Framework for Drugs and Medical Devices. |
|
|
86 |
Modifications/ Clarifications in the Operational Guidelines for the Production Linked Incentive (PU) Scheme for Pharmaceuticals - Dated 11th March, 2024 |
|
|
87 |
Guidelines for the Scheme (Strengthening of Pharmaceuticals Industry (SPI)) - Revamping of the PTUAS sub-scheme and Notification of the modification in the guidelines - reg. |
|
|
88 |
Public Notice dated 08.03.2024: Inviting details of local manufacturers of specific Drugs/Medicines/Pharmaceutical Formulations |
|
|
89 |
Invitation of applications under the Scheme Assistance to Medical Device Clusters for Common Facilities (AMD-CF)-regarding. |
|
|
90 |
Result of Consultant's interview |
|
|
91 |
Examination Call letter for Young Professionals |
|
|
92 |
Extension of Timeline for Invitation of Applications from eligible category B Applicants under the revised guidelines of PLI - Medical Devices till 29.02.2024- reg |
|
|
93 |
Notice for Invitation of applications under the Scheme 'Assistance to Medical Device Clusters for Common Facilities' (AMD-CF)-regarding. |
|
|
94 |
Study on Upgrading NIPERs to meet evolving needs of Pharmaceutical business and NIPERs in top 50 in world ranking |
|
|
95 |
Eligible/ineligible candidates for the post of Consultant. |
|
|
96 |
Modifications in the guidelines of Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of Medical Devices (PLI - MD) to invite applications for the eligible products as per Annexure-1A for Category-B applicant dated 19.12.2023 |
|
|
97 |
Invitation of applications from eligible Category-B applicants for 30 days under the corrigendum/addendum dated 19/12/2023 read with the revised guidelines of PLI scheme for promoting domestic manufacturing of the Medical Devices dated 25.02.2023- reg. |
|
|
98 |
Constitution Day Celebrations -reg |
|
|
99 |
Study on CRO Sector in India |
|
|
100 |
Revision of Fellowship for PhD Scholars of NIPERs |
|
औषध विभाग
Department of
